|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"kuo shi yu"
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2023-4-29 |
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
|
郭欣瑜; Kuo, Shi-Yu; Wu, Juei-Seng;Hong, Tzu-Chun;Wu, Hung-Tsung;Lin, Yih-Jyh;Chang, Ting-Tsung;Wang, Chung-Teng;Liu, Wen-Chun;Hsieh, Ming-Tsung;Wu, I-Chin;Chen, Po-Jun;Chen, Chiung-Yu;Lin, Sheng-Hsiang;Chuang, Chiao-Hsiung;Han, Meng-Zhi;Chen, Huang-Pin;Tsai, Hong-Ming;Kuo, Hsin-Yu |
| 國立成功大學 |
2023-2 |
Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma
|
Chiang, Hsueh-Chien;Lee, Yang-Cheng;Chang, Ting-Tsung;Lin, Yih-Jyh;Wu, Hung-Tsung;Wang, Chung-Teng;Chen, Chiung-Yu;Chen, Po-Jun;Hsieh, Ming-Tsung;Lin, Sheng-Hsiang;Chen, Shang-Hung;Chuang, Chiao-Hsiung;Wu, I-Chin;Hong, Tzu-Chun;Wu, Juei-Seng;Han, Meng-Zhi;Chen, Wei-Ting;Chiang, Chien-Ming;Hung, Kuan-Kai;Kuo, Hsin-Yu; Kuo, Shi-Yu; 郭欣瑜 |
| 國立成功大學 |
2022-11 |
Real-world comparative effectiveness of nivolumab versus pembrolizumab in patients with unresectable hepatocellular carcinoma
|
郭欣瑜; Kuo, Shi-Yu; Kuo, Hsin-Yu;Han, Meng-Zhi;Liao, Chih-Hsiang;Lin, Yih-Jyh;Wang, Chung-Teng;Chen, Shang-Hung;Chang, Ting-Tsung;Chen, Po-Jun;Lin, Sheng-Hsiang;Chen, Chiung-Yu;Chuang, Chiao-Hsiung;Wu, I-Chin;Wu, Juei-Seng;Hong, Tzu-Chun;Hsieh, Ming-Tsung;Lee, Yang-Cheng;Wu, Hung-Tsung;Tsai, Hong-Ming |
| 國立成功大學 |
2021-7 |
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
|
郭欣瑜; Kuo, Shi-Yu; Tsai, Hong-Ming;Han, Meng-Zhi;Lin, Yih-Jyh;Chang, Ting-Tsung;Chen, Chiung-Yu;Cheng, Pin-Nan;Chuang, Chiao-Hsiung;Wu, I-Chin;Chen, Po-Jun;Kang, Jui-Wen;Chiu, Yen-Cheng;Chiu, Hung-Chih;Chien, Shih-Chieh;Kuo, Hsin-Yu |
| 國立成功大學 |
2020-5-1 |
Impact of immune checkpoint inhibitors with or without a combination of tyrosine kinase inhibitors on organ-specific efficacy and macrovascular invasion in advanced hepatocellular carcinoma
|
Kuo, Hsin-Yu;Chiang, Nai-Jung;Chuang, Chiao-Hsiung;Chen, Chiung-Yu;Wu, I-Chin;Chang, Ting-Tsung;Tsai, Hong-Ming;Lin, Yih-Jyh; Kuo, Shi-Yu; 郭欣瑜 |
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
